screen_shot_2013-01-11_at_10

Dominic Atkins joins Clinigen GAP in senior commercial role

January 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Clinigen, Dominic Atkins

Pharma services company Clinigen Global Access Programs (Clinigen GAP) has appointed Dominic Atkins as global business development director. In this …

janssen image

Janssen’s diabetes drug Invokana recommended

January 11, 2013
Sales and Marketing Janssen, SGLT2, canagliflozin, diabetes, invokana

An FDA advisory committee has recommended Janssen’s new diabetes treatment canagliflozin for approval. To be marketed under the name Invokana, …

GSK image

EU submission for GSK and Theravance COPD drug

January 11, 2013
Sales and Marketing COPD, GSK, Theravance, UMEC/VI

GlaxoSmithKline and Theravance have submitted their chronic obstructive pulmonary disease (COPD) drug UMEC/VI to European regulators. The application follows the …

screen_shot_2013-01-11_at_09

Lundbeck appoints new global pricing and market access VP

January 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eggert, Jaszewski, Lundbeck

Barbara Jaszewski, has been appointed vice president of global pricing and market access at Lundbeck. She will be in charge …

Public health budget ring-fenced

January 11, 2013
Sales and Marketing Hunt, NHS, government

Local authorities are to receive a total of £5.45 billion from the government over the next two years to spend …

1301che_dr_abdulmajeed_raji

Cherwell appoints product specialist

January 11, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Cherwell Laboratories

Pharma supplier firm Cherwell Laboratories has announced the appointment of Abdulmajeed Raji as microbiology product specialist. Prior to joining Cherwell, …

FDA image

FDA vote on J&J diabetes drug

January 10, 2013
Sales and Marketing EU, FDA, J&J, JJ, Janssen, canagliflozin

Key advisers to the FDA are meeting today to decide whether Janssen Pharmaceuticals’ type II diabetes drug canagliflozin is safe …

thomas_monarth

Hookipa Biotech hires two officers

January 10, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Farshad Guirakhoo, Hookipa, Thomas Monarth

Vaccines biotech firm Hookipa Biotech AG has appointed two new members to its management team. Thomas Monath (pictured) joins as …

Global agency network welcomes new members

January 10, 2013
Medical Communications Indigenus, Lindh & Partners, PharMa International

A global network of independent healthcare agencies has welcomed two new members to the group. Tokyo-based PharMa International and Swedish …

Hunt image

£120m health research boost

January 10, 2013
Sales and Marketing Hunt, NHS, NIHR, TXA

The Department of Health is putting £120 million of new funding into health research over the next five years in …

Dorrell image

CQC ‘needs urgent overhaul’, say MPs

January 9, 2013
Sales and Marketing CQQ, Dorrell, NHS, select committee

England’s health and social care regulator, the Care Quality Commission (CQC), must overhaul its governance structures ‘as a matter of …

Gilead image

Gilead licences MacroGenics technology

January 9, 2013
Research and Development, Sales and Marketing DART, Gilead, MacroGenics

Private biotech company MacroGenics has licenced its bi-specific antibody platform technology to Gilead Sciences for products aimed at four unnamed …

prne-mapigroup-jamesmkaris-1y-2high

MAPI Group hires James Karis as chief executive

January 9, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing James Karis, MAPI

Healthcare services group MAPI has named James Karis as its chief executive. MAPI looks to Karis to consolidate its success …

SHL to present & exhibit at 10th Annual BIO Asia International Conference

January 9, 2013
Manufacturing and Production auto injector, autoinjector, shl events

SHL will be presenting and exhibiting at the upcoming 10th Annual BIO Asia International Conference from January 29-30th in Tokyo, …

Private equity firm pays $195m for contract manufacturer JHP

January 8, 2013
Manufacturing and Production CMO, JHP, Warburg Pincus

Private equity group Warburg Pincus has acquired sterile injectable drug manufacturer JHP Pharmaceuticals from its current owner Morgan Stanley. The …

Questcor buys API specialist BioVectra for $51m

January 8, 2013
Manufacturing and Production API, Achtar, BioVectra, Questcor

US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …

Boehringer hands back Lilly drug

January 8, 2013
Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly

Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …

Valeant image

Valeant shuts plant in Brazil, second to follow

January 8, 2013
Manufacturing and Production Brazil, Medicis, Valeant

Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the …

Eisai image

Eisai and Novartis part ways

January 8, 2013
Sales and Marketing COPD, Eisai, Novartis, Onbrez, Spiriva

Novartis and Eisai have abandoned their co-promotion agreement for three of Novartis’ chronic obstructive pulmonary disease treatments. The move follows …

Novo Nordisk appoints Curtis Oltmans to US executive team

January 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Oltmans

Novo Nordisk has announced that Curtis Oltmans has been promoted to corporate vice president and general counsel, Legal and Quality …

The Gateway to Local Adoption Series

Latest content